buserelin

(redirected from Suprefact)

buserelin

A long-acting GnRH-gonadotropin-releasing hormone analogue, which causes permanent pitutary stimulation and downregulates the pituitary-gonadal axis, blocking testosterone production in the testes; it has been used to treat metastatic prostate and breast cancer, to create pseudomenopause to reduce the size and number of endometriotic lesions and fibroids. It has also been used for hirsutism, to induced ovulation and for in vitro fertilisation.

buserelin

Suprefact® Infertility A long-acting gonadotropin-releasing hormone analogue which downregulates the pituitary-gonadal axis, block testosterone production in the testes; it has been used to treat metastatic prostate CA. See Disease flare.

buserelin

A gonadothropin-releasing hormone drug used in the treatment of ENDOMETRIOSIS and INFERTILITY. Brand names are Suprecur and Suprefact.
Mentioned in ?
References in periodicals archive ?
5 mg of buserelin, Suprefact, Serono), on day 21 of their menstrual cycle (1 wk before the expected menses).
After the initial work-up, controlled ovarian hyperstimulation (COH) was done with the long protocol: Gonadotropin-releasing hormone agonist (GnRH agonist; injection Suprefact 0.
In addition, the brand of LHRH agonist (Lupron [Abbott Laboratories, Saint Laurent,QC], Zoladex [AstraZeneca Canada, Mississauga, ON], Suprefact [sanofi-aventis, Laval, QC], Eligard [sanofi-aventis, Laval, QC], Trelstar [Watson Pharma Inc.
However this tremendous discrepancy in price does not simply include basic pain relief, but also antibiotics such as Dalacin and Augmentin, cancer medication such as Casodex and Suprefact, along with anti-depression medication such as Xanax and Lexotanil, among others.
Follicles were aspirated under ultrasound-guided transvaginal puncture after pituitary desensitization with Buserilin nasal spray (800 [micro]g daily; Suprefact, Hoechtst, Belgium) followed by human menopausal gonadotropin (hMG), only 2 ampules of 75 U daily until at least two follicles reached a diameter of 20 mm.
The endometriosis market will change dramatically following the patent expiry of key brands Lupron Depot, Zoladex and Suprefact.
2 mg buserelin, Suprefact, Serono, Rome, Italy), starting from the 21st day of the same cycle when melatonin was started.